Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 6483.83 | 578 / 578 | 94% | 231.72 | 1090 / 1155 |
breast | 93% | 1452.75 | 425 / 459 | 97% | 184.73 | 1080 / 1118 |
intestine | 92% | 1119.09 | 889 / 966 | 78% | 118.17 | 412 / 527 |
adrenal gland | 96% | 1796.89 | 247 / 258 | 71% | 89.53 | 163 / 230 |
bladder | 95% | 1186.05 | 20 / 21 | 71% | 131.52 | 358 / 504 |
prostate | 79% | 799.90 | 193 / 245 | 71% | 60.07 | 355 / 502 |
kidney | 56% | 696.10 | 50 / 89 | 92% | 259.92 | 828 / 901 |
stomach | 60% | 590.49 | 215 / 359 | 82% | 171.51 | 235 / 286 |
liver | 67% | 698.41 | 151 / 226 | 75% | 101.06 | 304 / 406 |
uterus | 56% | 458.15 | 96 / 170 | 85% | 149.86 | 389 / 459 |
brain | 46% | 557.64 | 1226 / 2642 | 94% | 255.93 | 662 / 705 |
thymus | 54% | 472.89 | 352 / 653 | 84% | 127.28 | 506 / 605 |
esophagus | 60% | 597.29 | 862 / 1445 | 75% | 102.86 | 138 / 183 |
ovary | 39% | 319.82 | 70 / 180 | 96% | 300.63 | 413 / 430 |
skin | 35% | 243.34 | 627 / 1809 | 90% | 220.19 | 425 / 472 |
pancreas | 26% | 240.46 | 84 / 328 | 91% | 208.33 | 162 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 504.77 | 29 / 29 |
spleen | 100% | 10134.89 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 2854.67 | 1190 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 170.83 | 41 / 45 |
blood vessel | 85% | 1645.07 | 1140 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 34111.61 | 763 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 68% | 97.36 | 54 / 80 |
heart | 52% | 480.66 | 450 / 861 | 0% | 0 | 0 / 0 |
muscle | 5% | 27.33 | 37 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0030900 | Biological process | forebrain development |
GO_0007165 | Biological process | signal transduction |
GO_0048678 | Biological process | response to axon injury |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032911 | Biological process | negative regulation of transforming growth factor beta1 production |
GO_0006968 | Biological process | cellular defense response |
GO_0002222 | Biological process | stimulatory killer cell immunoglobulin-like receptor signaling pathway |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0034241 | Biological process | positive regulation of macrophage fusion |
GO_0002223 | Biological process | stimulatory C-type lectin receptor signaling pathway |
GO_0032480 | Biological process | negative regulation of type I interferon production |
GO_1902685 | Biological process | positive regulation of receptor localization to synapse |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0050821 | Biological process | protein stabilization |
GO_0032816 | Biological process | positive regulation of natural killer cell activation |
GO_1900272 | Biological process | negative regulation of long-term synaptic potentiation |
GO_0032930 | Biological process | positive regulation of superoxide anion generation |
GO_0002274 | Biological process | myeloid leukocyte activation |
GO_1904151 | Biological process | positive regulation of microglial cell mediated cytotoxicity |
GO_2001206 | Biological process | positive regulation of osteoclast development |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0030889 | Biological process | negative regulation of B cell proliferation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0002282 | Biological process | microglial cell activation involved in immune response |
GO_0002283 | Biological process | neutrophil activation involved in immune response |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0009986 | Cellular component | cell surface |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TYROBP |
Protein name | TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein) TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) Transmembrane immune signaling adaptor TYROBP |
Synonyms | DAP12 KARAP |
Description | FUNCTION: Adapter protein which non-covalently associates with activating receptors found on the surface of a variety of immune cells to mediate signaling and cell activation following ligand binding by the receptors . TYROBP is tyrosine-phosphorylated in the ITAM domain following ligand binding by the associated receptors which leads to activation of additional tyrosine kinases and subsequent cell activation . Also has an inhibitory role in some cells . Non-covalently associates with activating receptors of the CD300 family to mediate cell activation . Also mediates cell activation through association with activating receptors of the CD200R family (By similarity). Required for neutrophil activation mediated by integrin (By similarity). Required for the activation of myeloid cells mediated by the CLEC5A/MDL1 receptor . Associates with natural killer (NK) cell receptors such as KIR2DS2 and the KLRD1/KLRC2 heterodimer to mediate NK cell activation . Also enhances trafficking and cell surface expression of NK cell receptors KIR2DS1, KIR2DS2 and KIR2DS4 and ensures their stability at the cell surface . Associates with SIRPB1 to mediate activation of myeloid cells such as monocytes and dendritic cells . Associates with TREM1 to mediate activation of neutrophils and monocytes . Associates with TREM2 on monocyte-derived dendritic cells to mediate up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival . Association with TREM2 mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages . Stabilizes the TREM2 C-terminal fragment (TREM2-CTF) produced by TREM2 ectodomain shedding which suppresses the release of pro-inflammatory cytokines . In microglia, required with TREM2 for phagocytosis of apoptotic neurons (By similarity). Required with ITGAM/CD11B in microglia to control production of microglial superoxide ions which promote the neuronal apoptosis that occurs during brain development (By similarity). Promotes pro-inflammatory responses in microglia following nerve injury which accelerates degeneration of injured neurons (By similarity). Positively regulates the expression of the IRAK3/IRAK-M kinase and IL10 production by liver dendritic cells and inhibits their T cell allostimulatory ability (By similarity). Negatively regulates B cell proliferation . Required for CSF1-mediated osteoclast cytoskeletal organization (By similarity). Positively regulates multinucleation during osteoclast development (By similarity). . |
Accessions | K7ES93 ENST00000544690.6 [O43914-3] ENST00000589517.1 [O43914-2] X6RGC9 O43914 K7EKK0 ENST00000424586.7 ENST00000586946.1 ENST00000262629.9 [O43914-1] ENST00000585901.6 ENST00000587837.5 |